Cadrenal Therapeutics Cash Used In Operating Activities Totaled $1.8M During Q1 2024; As Of March 31, 2024, Cash Balances Were $6.6M
Cadrenal Therapeutics Cash Used In Operating Activities Totaled $1.8M During Q1 2024; As Of March 31, 2024, Cash Balances Were $6.6M
2024年第一季度，Cadrenal Therapeutics用于经营活动的现金总额为180万美元；截至2024年3月31日，现金余额为660万美元
Cadrenal Therapeutics Cash Used In Operating Activities Totaled $1.8M During Q1 2024; As Of March 31, 2024, Cash Balances Were $6.6M
2024年第一季度，Cadrenal Therapeutics用于经营活动的现金总额为180万美元；截至2024年3月31日，现金余额为660万美元
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。